{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:12:36Z","timestamp":1778659956588,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Grant for Innovation Team Program of Heilongjiang Province"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272345"],"award-info":[{"award-number":["82272345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13192-y","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:45:03Z","timestamp":1775126703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Declining prevalence of multidrug-resistant but comparatively high quinolone-resistant tuberculosis in Heilongjiang Province, China: 2013\u20132022 trend"],"prefix":"10.1186","volume":"26","author":[{"given":"Jin-Long","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Yu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Starshinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Kudryavtsev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian-Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"13192_CR1","volume-title":"Licence: CC BY-NC-SA 3.0 IGO","author":"Global tuberculosis report 2025","year":"2025","unstructured":"Global tuberculosis report 2025. Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2025."},{"issue":"1","key":"13192_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12879-016-1848-9","volume":"16","author":"D Li","year":"2016","unstructured":"Li D, Wang JL, Ji BY, Cui JY, Pan XL, Fan CL, et al. Persistently high prevalence of primary resistance and multidrug resistance of tuberculosis in Heilongjiang Province, China. BMC Infect Dis. 2016;16(1):516.","journal-title":"BMC Infect Dis"},{"issue":"23","key":"13192_CR3","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","volume":"366","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161\u201370.","journal-title":"N Engl J Med"},{"key":"13192_CR4","volume-title":"WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment. 2022 update ed","author":"WHO","year":"2022","unstructured":"WHO. WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment. 2022 update ed. Geneva: World Health Organization; 2022."},{"key":"13192_CR5","first-page":"7","volume":"11","author":"AH Wu","year":"2012","unstructured":"Wu AH, Li CH, Wen XM, Ren N. Nationl healthcare-associated infection surveillance system point prevalence survey of antimcrobial use in 740 Chinese hospitals in 2010 [in Chinese]. Chin J Infect Control. 2012;11:7\u201311.","journal-title":"Chin J Infect Control"},{"key":"13192_CR6","first-page":"63","volume":"14","author":"HY Jia","year":"2012","unstructured":"Jia HY. Survey on using condition of antibiotics in inpatients [in Chinese]. Mod Med J China. 2012;14:63\u20137.","journal-title":"Mod Med J China"},{"key":"13192_CR7","first-page":"795","volume":"18","author":"HQ Chen","year":"2011","unstructured":"Chen HQ, Zhang L. Clinical application of quinolones in pediatric infectious diseases [in Chinese]. Clin Med Eng. 2011;18:795\u201396.","journal-title":"Clin Med Eng"},{"key":"13192_CR8","first-page":"2165","volume":"22","author":"YD Zhang","year":"2012","unstructured":"Zhang YD, Zong JS, Sun YX, Pan LZ, Hu ZY, Liang XF, et al. Cross-sectional study on nosocomial infections and use of antibiotics in hospitalized patients [in Chinese]. Chin J Nosocomiol. 2012;22:2165\u201368.","journal-title":"Chin J Nosocomiol"},{"issue":"3","key":"13192_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3201\/eid1303.061400","volume":"13","author":"NS Shah","year":"2007","unstructured":"Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Mart\u00edn-Casabona N, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. Mar; 2007;13(3):380\u20137.","journal-title":"Emerg Infect Dis"},{"key":"13192_CR10","volume-title":"Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: emergency update. 2008 update ed","author":"WHO","year":"2008","unstructured":"WHO. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: emergency update. 2008 update ed. Geneva: World Health Organization; 2008."},{"key":"13192_CR11","volume-title":"27\u201329 October 2020","author":"Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis","year":"2021","unstructured":"Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis. 27\u201329 October 2020. Geneva: World Health Organization; 2021. 198 CC BY-NC-SA 3.0 IGO."},{"key":"13192_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/524017","volume":"46","author":"CY Jeon","year":"2008","unstructured":"Jeon CY, Hwang SH, Min JH, Prevots DR, Goldfeder LC, Lee H, et al. Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Clin Infect Dis. 2008;46:42\u20139.","journal-title":"Clin Infect Dis"},{"key":"13192_CR13","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0140-6736(12)60734-X","volume":"380","author":"T Dalton","year":"2012","unstructured":"Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN, et al. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet. 2012;380:1406\u201317.","journal-title":"Lancet"},{"key":"13192_CR14","volume-title":"Procedure for laboratory examination of tuberculosis","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Pang Y. Procedure for laboratory examination of tuberculosis. Beijing: People\u2019s Medical Publishing House; 2015. (In Chinese)."},{"issue":"19","key":"13192_CR15","first-page":"2925","volume":"31","author":"DP Wang","year":"2021","unstructured":"Wang DP, Bao XD, Liang L, Jiang Y, Li J, Yu SQ, et al. Drug resistance trends of Mycobacterium tuberculosis in a hospital in Anhui from 2012\u20132019. Chin J Hosp Infect. 2021;31(19):2925\u20139. (In Chinese).","journal-title":"Chin J Hosp Infect"},{"key":"13192_CR16","doi-asserted-by":"crossref","unstructured":"Woods GL, Brown-Elliott BA, Conville PS, Desmond EP, Hall GS, Lin G, et al. CLSI standards: guidelines for health care excellence. In: Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes. Wayne (PA): Clinical and Laboratory Standards Institute; 2011.","DOI":"10.1128\/9781555816728.ch73"},{"issue":"04","key":"13192_CR17","first-page":"429","volume":"23","author":"YM Li","year":"2024","unstructured":"Li YM, Chen LH, Fu CC, et al. Monitoring of antibiotic resistance of respiratory Isolates in the bacterial resistance surveillance network of hunan province, 2012\u20132021 [J]. Chin J Infect Control. 2024;23(04):429\u201341. (In Chinese).","journal-title":"Chin J Infect Control"},{"key":"13192_CR18","volume-title":"Global tuberculosis report 2022","author":"WHO","year":"2022","unstructured":"WHO. Global tuberculosis report 2022. Geneva: World Health Organization; 2022."},{"key":"13192_CR19","doi-asserted-by":"crossref","unstructured":"Starshinova A, Dovgalyk I, Belyaeva E, Glushkova A, Osipov N, Kudlay D. Efficacy of tuberculosis treatment in patients with drug-resistant tuberculosis with the use of bedaquiline: the experience of the Russian Federation. Antibiot (Basel), 2022;11(11).","DOI":"10.3390\/antibiotics11111622"},{"issue":"1","key":"13192_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s44197-023-00085-5","volume":"13","author":"A Starshinova","year":"2023","unstructured":"Starshinova A, Belyaeva E, Doktorova N, Korotkevich I, Kudlay D. Tuberculosis in the Russian Federation: Prognosis and Epidemiological Models in a Situation After the COVID-19 Pandemic. J Epidemiol Glob Health. 2023;13(1):11\u201322.","journal-title":"J Epidemiol Glob Health"},{"issue":"08","key":"13192_CR21","first-page":"1254","volume":"30","author":"XY Yang","year":"2025","unstructured":"Yang XY, Dai XW, Li J, et al. Study on the application of microplate culture method in drug sensitivity test of rifampin-resistant Mycobacterium tuberculosis [J]. J Clin pulmonary Med. 2025;30(08):1254\u20139. (In Chinese).","journal-title":"J Clin pulmonary Med"},{"issue":"04","key":"13192_CR22","first-page":"382","volume":"6","author":"JH Yang","year":"2025","unstructured":"Yang JH, Xia H, Huang HR, et al. Expert consensus on standardization of drug sensitivity test of Mycobacterium tuberculosis by broth dilution method in China [J]. J Tuberculosis Lung Dis. 2025;6(04):382\u201392. (In Chinese).","journal-title":"J Tuberculosis Lung Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13192-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13192-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13192-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:47:31Z","timestamp":1778658451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13192-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13192"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13192-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was reviewed and approved by the Institutional Research Board (IRB) of Harbin medical University (HMUIRB20160001). The DST data of the bacterial isolates distinguished according to the isolate number were from the records in the clinical laboratory of the hospital, and the patient information was removed prior to analysis. Therefore, the IRB of Harbin medical University waived the requirement to obtain informed consent from the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"943"}}